Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) major shareholder Fosun Pharmaceutical Shanghai sold 1,300 shares of the business's stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $13.12, for a total transaction of $17,056.00. Following the sale, the insider now owns 66,467 shares in the company, valued at $872,047.04. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.
Fosun Pharmaceutical Shanghai also recently made the following trade(s):
- On Thursday, October 10th, Fosun Pharmaceutical Shanghai sold 3,000 shares of Nature's Sunshine Products stock. The shares were sold at an average price of $13.39, for a total transaction of $40,170.00.
- On Tuesday, October 8th, Fosun Pharmaceutical Shanghai sold 1,800 shares of Nature's Sunshine Products stock. The stock was sold at an average price of $13.13, for a total transaction of $23,634.00.
- On Tuesday, October 1st, Fosun Pharmaceutical Shanghai sold 1,399 shares of Nature's Sunshine Products stock. The shares were sold at an average price of $13.54, for a total transaction of $18,942.46.
Nature's Sunshine Products Price Performance
Watch this before it gets removed
From Porter & Company | Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.
Nature's Sunshine Products stock opened at $12.92 on Wednesday. The stock has a market cap of $241.99 million, a PE ratio of 15.20 and a beta of 0.87. The stock's fifty day moving average is $13.42 and its two-hundred day moving average is $15.53. Nature's Sunshine Products, Inc. has a 1-year low of $10.81 and a 1-year high of $21.72.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.18). The business had revenue of $110.55 million for the quarter. Nature's Sunshine Products had a return on equity of 9.79% and a net margin of 3.50%.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on NATR. DA Davidson reduced their price objective on Nature's Sunshine Products from $23.00 to $21.00 and set a "buy" rating on the stock in a research note on Monday, August 12th. Canaccord Genuity Group began coverage on Nature's Sunshine Products in a research report on Friday, September 13th. They issued a "buy" rating and a $18.00 price target on the stock. StockNews.com upgraded Nature's Sunshine Products from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, September 10th. Finally, Canaccord Genuity Group assumed coverage on shares of Nature's Sunshine Products in a research note on Friday, September 13th. They set a "buy" rating and a $18.00 target price on the stock.
Check Out Our Latest Analysis on Nature's Sunshine Products
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the stock. Gladius Capital Management LP lifted its position in Nature's Sunshine Products by 23.9% in the second quarter. Gladius Capital Management LP now owns 6,862 shares of the company's stock valued at $103,000 after acquiring an additional 1,325 shares during the last quarter. Lazard Asset Management LLC increased its position in shares of Nature's Sunshine Products by 16.5% during the first quarter. Lazard Asset Management LLC now owns 7,040 shares of the company's stock worth $146,000 after purchasing an additional 998 shares in the last quarter. XTX Topco Ltd purchased a new stake in shares of Nature's Sunshine Products in the 2nd quarter valued at about $180,000. Bailard Inc. acquired a new stake in shares of Nature's Sunshine Products in the 2nd quarter valued at about $197,000. Finally, SG Americas Securities LLC grew its stake in Nature's Sunshine Products by 48.7% during the 1st quarter. SG Americas Securities LLC now owns 10,716 shares of the company's stock worth $223,000 after buying an additional 3,510 shares during the last quarter. Institutional investors and hedge funds own 79.40% of the company's stock.
About Nature's Sunshine Products
(
Get Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
